Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the <scp>EAACI AIT</scp> Guidelines Project
Andreas Bonertz(Paul Ehrlich Institut), Stefan Vieths(Paul Ehrlich Institut), Roy Gerth van Wijk(Erasmus MC), Jennifer Bridgewater(United States Food and Drug Administration), Lars K. Poulsen(Gentofte Hospital), Elizabeth Angier(Northern General Hospital), Ruby Pawankar(Nippon Medical School), С. Бонини(University of Campania "Luigi Vanvitelli"), Aziz Sheikh(University of Oxford), Marcos Timón(Agencia Española de Medicamentos y Productos Sanitarios), Ronald L. Rabin(Center for Biologics Evaluation and Research), Ioana Agache(Transylvania University of Brașov), Susanne Halken(University of Southern Denmark), Dermot Ryan(University of Edinburgh), Óscar Palomares(Universidad Complutense de Madrid), Oliver Pfaar(Heidelberg University), Ronald van Ree(Amsterdam University Medical Centers), Montserrat Fernández‐Rivas(Hospital Clínico San Carlos), Ludger Klimek(Zentrum für Rhinologie und Allergologie), Gunter J. Sturm(Medical University of Graz), Domingo Barber(Universidad San Pablo CEU), Susanne Lau(Charité - Universitätsmedizin Berlin), Cezmi A. Akdiş(University of Zurich), Marek Jutel(Wroclaw Medical University), Giovanni Battista Pajno(University of Messina), Jorge Goldstein(Universidad de Buenos Aires), Graham Roberts(St Mary's Hospital), Thomas B. Casale(University of South Florida), Marcel H. N. Hoefnagel(Medicines Evaluation Board), Antonella Muraro(University of Padua), D. Hamerlijnk(Lung Foundation Netherlands), Claudio Rhyner(CK-CARE), C. Pini(Istituto Superiore di Sanità), E.‐M. Varga(Medical University of Graz), Jay E. Slater(United States Food and Drug Administration)
Cited by 78
Related Papers
Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium
|Journal of Allergy and Clinical Immunology|2006|2.3k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
|Journal of Allergy and Clinical Immunology|2017|2k
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
|American Journal of Respiratory and Critical Care Medicine|2009|1.9k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
|Journal of Allergy and Clinical Immunology|2010|1.8k
Risk factors for severe and critically ill COVID‐19 patients: A review
|Allergy|2020|1.4k